<div>
<table style='width: 100%' class="ke-table-vertical">
<tr>
<font size="3" color="red">A- MEDICAL CARE</font>
</tr>
<tr>
<th>

</th>
<th>
Adult Male
</th>
<th>
Adult Female
</th>
<th>
Total
</th>
</tr>

<tr>
<td>1.New patients enrolled in HIV care during this month</td>
<td>${noOfNewPatientEnrolledInHivCareForMale}</td>
<td>${noOfNewPatientEnrolledInHivCareForFemale}</td>
<td>${noOfNewPatientEnrolledInHivCareTotal}</td>
</tr>

<tr>
<td>2.No. of patients treated for  Opportunistic Infections during this month </td>
<td>${noOfPatientTreatedForOpportunisticInfectionsForMale}</td>
<td>${noOfPatientTreatedForOpportunisticInfectionsForFemale}</td>
<td>${noOfPatientTreatedForOpportunisticInfectionsTotal}</td>
</tr>

<tr>
<td>3.No. of medically eligible patients currently remaining on waiting list for ART at the end of this month</td>
<td>${noOfMedicallyEligiblePatientsWaitingForARTForMale}</td>
<td>${noOfMedicallyEligiblePatientsWaitingForARTForFemale}</td>
<td>${noOfMedicallyEligiblePatientsWaitingForARTTotal}</td>

<tr>
<td>4.Enrollment on ART</td>
<td> </td>
<td> </td>
<td> </td>
</tr>

<tr>
<td>4.1 Cumulative no. of active follow up  patients ever started on ART at the beginning of this month</td>
<td>${cumulativeNoOfActiveFollowUpPatientsStartedAtBegOfMonthForMale}</td>
<td>${cumulativeNoOfActiveFollowUpPatientsStartedAtBegOfMonthForFemale}</td>
<td>${cumulativeNoOfActiveFollowUpPatientsStartedAtBegOfMonthTotal}</td>
</tr>

<tr>
<td>4.2 New patients started on ART during this month</td>
<td>${noOfNewPatientsStartedOnARTForMale}</td>
<td>${noOfNewPatientsStartedOnARTForFemale}</td>
<td>${noOfNewPatientsStartedOnARTTotal}</td>
</tr>

<tr>
<td>4.3 No. of patients on ART transferred in this month</td>
<td>${noOfPatientsOnARTTransferredInForMale}</td>
<td>${noOfPatientsOnARTTransferredInForFemale}</td>
<td>${noOfPatientsOnARTTransferredInTotal}</td>
</tr>

<tr>
<td>4.4 Cumulative no. of active follow up patients ever started on ARTat the end of this month(=4.1+4.2+4.3)</td>
<td>${noOfCumulativeNoOfActiveFollowUpPatientsStartedAtEndOfMonthForMale}</td>
<td>${noOfCumulativeNoOfActiveFollowUpPatientsStartedAtEndOfMonthForFemale}</td>
<td>${noOfCumulativeNoOfActiveFollowUpPatientsStartedAtEndOfMonthTotal}</td>
</tr>

<tr>
<td>5. Outcomes on ART</td>
<td> </td>
<td> </td>
<td> </td>
</tr>

<tr>
<td>5.1 No. of death reported at the end of this month</td>
<td>${noOfDeathReportedForMale}</td>
<td>${noOfDeathReportedForFemale}</td>
<td>${noOfDeathReportedTotal}</td>
</tr>

<tr>
<td>5.2 No. of patients transferred out under ARV at the end of this month</td>
<td>${noOfPatientsTransferredOutUnderARVForMale}</td>
<td>${noOfPatientsTransferredOutUnderARVForFemale}</td>
<td>${noOfPatientsTransferredOutUnderARVTotal}</td>
</tr>

<tr>
<td>5.3 No. of patients missing/lost to follow-up at the end of this month</td>
<td>${noOfPatientsLostToFollowUpForMale}</td>
<td>${noOfPatientsLostToFollowUpForFemale}</td>
<td>${noOfPatientsLostToFollowUpTotal}</td>
</tr>

<tr>
<td>5.4 No. of patients stopping ART at the end of this month</td>
<td>${noOfPatientsStopppedARTForMale}</td>
<td>${noOfPatientsStopppedARTForFemale}</td>
<td>${noOfPatientsStopppedARTTotal}</td>
</tr>

<tr>
<td>5.5 No. of patients on ART at the end of this month {=4.4- (5.1+5.2+5.3+5.4)}</td>
<td>${noOfPatientsOnARTForMale}</td>
<td>${noOfPatientsOnARTForFemale}</td>
<td>${noOfPatientsOnARTTotal}</td>
</tr>

<tr>
<td>w 5.5.1 Among them, no. on original 1st line regimen</td>
<td>${noOfPatientsOnOriginalFirstLineRegimForMale}</td>
<td>${noOfPatientsOnOriginalFirstLineRegimForFemale}</td>
<td>${noOfPatientsOnOriginalFirstLineRegimTotal}</td>
</tr>

<tr>
<td>w 5.5.2 No. on substituted 1st line regimen</td>
<td>${noOfPatientsSubstitutedFirstLineRegimForMale}</td>
<td>${noOfPatientsSubstitutedFirstLineRegimForFemale}</td>
<td>${noOfPatientsSubstitutedFirstLineRegimTotal}</td>
</tr>

<tr>
<td>w 5.5.3 No. switched to 2nd line regimen</td>
<td>${noOfPatientsSubstitutedSecondLineRegimForMale}</td>
<td>${noOfPatientsSubstitutedSecondLineRegimForFemale}</td>
<td>${noOfPatientsSubstitutedSecondLineRegimTotal}</td>
</tr>

<tr>
<td>w 5.5.4 No. switched to 3rd line regimen</td>
<td>${noOfPatientsSubstitutedThirdLineRegimForMale}</td>
<td>${noOfPatientsSubstitutedThirdLineRegimForFemale}</td>
<td>${noOfPatientsSubstitutedThirdLineRegimTotal}</td>
</tr>

<tr>
<td>6. TB/HIV  programme</td>
<td> </td>
<td> </td>
<td> </td>
</tr>

<tr>
<td>6.1 No. of  HIV positive TB patients who have received ART during this month</td>
<td>${noOfHIVPositiveTBPatientsForMale}</td>
<td>${noOfHIVPositiveTBPatientsForFemale}</td>
<td>${noOfHIVPositiveTBPatientsTotal}</td>
</tr>

<tr>
<td>6.2  Cumulative no. of HIV positive TB patients who received ART at the end of this month</td>
<td>${cumulativeNoOfHIVPositiveTBPatientsForMale}</td>
<td>${cumulativeNoOfHIVPositiveTBPatientsForFemale}</td>
<td>${cumulativeNoOfHIVPositiveTBPatientsTotal}</td>
</tr>

<tr>
<td>7. TREATMENT ADHERENCE</td>
<td> </td>
<td> </td>
<td> </td>
</tr>

<tr>
<td>7.2.1 < 5% of doses missed in a period of 30 days</td>
<td></td>
<td></td>
<td>${noOfPatientsAssessedForAdherenceDuringTheLastMonthLevelOneTot}</td>
</tr>

<tr>
<td>7.2.2 (5-20)% of doses missed in a period of 30 days</td>
<td></td>
<td></td>
<td>${noOfPatientsAssessedForAdherenceDuringTheLastMonthLevelTwoTot}</td>
</tr>

<tr>
<td>7.2.3 >20% of doses missed in a period of 30 days</td>
<td></td>
<td></td>
<td>${noOfPatientsAssessedForAdherenceDuringTheLastMonthLevelThreeTot}</td>
</tr>

<tr>
<td>8. Performance scale</td>
<td> </td>
<td> </td>
<td> </td>
</tr>

<tr>
<td>8.1 Performance Scale A</td>
<td>${noOfPatientsOnPerformanceScaleAForMale}</td>
<td>${noOfPatientsOnPerformanceScaleAForFemale}</td>
<td>${noOfPatientsOnPerformanceScaleATotal}</td>
</tr>

<tr>
<td>8.2 Performance Scale B</td>
<td>${noOfPatientsOnPerformanceScaleBForMale}</td>
<td>${noOfPatientsOnPerformanceScaleBForFemale}</td>
<td>${noOfPatientsOnPerformanceScaleBTotal}</td>
</tr>

<tr>
<td>8.3 Performance Scale C</td>
<td>${noOfPatientsOnPerformanceScaleCForMale}</td>
<td>${noOfPatientsOnPerformanceScaleCForFemale}</td>
<td>${noOfPatientsOnPerformanceScaleCTotal}</td>
</tr>

<tr>
<td>10. LAB</td>
<td></td>
<td></td>
<td></td>
</tr>

<tr>
<td>10.1 No. of patients tested for CD4 count</td>
<td>${noOfPatientsTestedForCD4CountForMale}</td>
<td>${noOfPatientsTestedForCD4CountForFemale}</td>
<td>${noOfPatientsTestedForCD4CountTotal}</td>
</tr>

<tr>
<td>10.2 No. of patients tested for viral load</td>
<td>${noOfPatientsTestedForViralLoadForMale}</td>
<td>${noOfPatientsTestedForViralLoadForFemale}</td>
<td>${noOfPatientsTestedForViralLoadTotal}</td>
</tr>

<table style='width: 100%' class="ke-table-vertical">
<tr>
<th>9.Risk Factors Code</th>
<th>1</th>
<th>2</th>
<th>3</th>
<th>4</th>
<th>5</th>
<th>6</th>
<th>7</th>
</tr>

<tr>
<td>Male</td>
<td>${noOfPatientSWithRiskFactorsCodeOneForMale}</td>
<td>${noOfPatientSWithRiskFactorsCodeTwoForMale}</td>
<td>${noOfPatientSWithRiskFactorsCodeThreeForMale}</td>
<td>${noOfPatientSWithRiskFactorsCodeFourForMale}</td>
<td>${noOfPatientSWithRiskFactorsCodeFiveForMale}</td>
<td>${noOfPatientSWithRiskFactorsCodeSixForMale}</td>
<td>${noOfPatientSWithRiskFactorsCodeSevenForMale}</td>
</tr>

<tr>
<td>Female</td>
<td>${noOfPatientSWithRiskFactorsCodeOneForFemale}</td>
<td>${noOfPatientSWithRiskFactorsCodeTwoForFemale}</td>
<td>${noOfPatientSWithRiskFactorsCodeThreeForFemale}</td>
<td>${noOfPatientSWithRiskFactorsCodeFourForFemale}</td>
<td>${noOfPatientSWithRiskFactorsCodeFiveForFemale}</td>
<td>${noOfPatientSWithRiskFactorsCodeSixForFemale}</td>
<td>${noOfPatientSWithRiskFactorsCodeSevenForFemale}</td>
</tr>
</table>
</table>
</div>

<div>
<table style='width: 100%' class="ke-table-vertical">
<tr>
<font size="3" color="red">B- PHARMACY</font>
</tr>
<br/>
<tr>
<font size="3" color="blue">11. REGIMEN AT THE END OF THE MONTH</font>
</tr>
<tr>
<th>
<font size="2" color="blue">Regimen</font>
</th>
<th>
<font size="2" color="blue">Type of Regimen</font>
</th>
<th>
<font size="2" color="blue">No. of Adult ART patients</font>
</th>
<th>
<font size="2" color="blue">Remark</font>
</th>
</tr>
<tr>
<td>AZT/3TC/NVP (300/150/200)mg</td>
<td>1st Line regimen</td>
<td>${noOfPatientsHavingFirstLineRegimen1}</td>
</tr>
<tr>
<td>AZT300/3TC150+NVP200</td>
<td>1st Line regimen</td>
<td> </td>
</tr>
<tr>
<td>AZT/3TC/LPV/r (300/150/200/50)mg</td>
<td>2nd Line regimen</td>
<td>${noOfPatientsHavingSecondLineRegimen1}</td>
</tr>
</table>
</div>

<div>
<table style='width: 100%' class="ke-table-vertical">
<tr>
<font size="3" color="red">Drug-Stocks</font>
</tr>
<br/>
<tr>
<th>
<font size="2" color="blue">Name of the drug (list ARV and OI drugs)</font>
</th>
<th>
<font size="2" color="blue">Stock dispensed during the month(C)</font>
</th>
</tr>
<tr>
<td>AZT/3TC/NVP (300/150/200)mg</td>
<td>${noOfPatientsHavingstockDispensed1}</td>
</tr>
<tr>
<td>AZT300/3TC150+NVP200</td>
<td>${noOfPatientsHavingstockDispensed2}</td>
</tr>
<tr>
<td>AZT/3TC/EFV (300/150/600)mg</td>
<td>${noOfPatientsHavingstockDispensed3}</td>
</tr>
<tr>
<td>AZT300/3TC150+EFV600</td>
<td>${noOfPatientsHavingstockDispensed4}</td>
</tr>
<tr>
<td>TDF/3TC/NVP (300/300/200)mg</td>
<td>${noOfPatientsHavingstockDispensed5}</td>
</tr>
<tr>
<td>TDF300/3TC300 + NVP200</td>
<td>${noOfPatientsHavingstockDispensed6}</td>
</tr>
<tr>
<td>TDF/3TC/EFV (300/300/600)mg</td>
<td>${noOfPatientsHavingstockDispensed7}</td>
</tr>
<tr>
<td>TDF300/3TC300+EFV400</td>
<td>${noOfPatientsHavingstockDispensed8}</td>
</tr>
<tr>
<td>TDF300/3TC300+EFV600</td>
<td>${noOfPatientsHavingstockDispensed9}</td>
</tr>
<tr>
<td>TDF/FTC/NVP (300/200/200)mg</td>
<td>${noOfPatientsHavingstockDispensed10}</td>
</tr>
<tr>
<td>TDF300/FTC200+NVP200</td>
<td>${noOfPatientsHavingstockDispensed11}</td>
</tr>
<tr>
<td>TDF/FTC/EFV (300/200/200)mg</td>
<td>${noOfPatientsHavingstockDispensed12}</td>
</tr>
<tr>
<td>TDF300/FTC200+EFV400</td>
<td>${noOfPatientsHavingstockDispensed13}</td>
</tr>
<tr>
<td>TDF/FTC/EFV (300/200/600)mg</td>
<td>${noOfPatientsHavingstockDispensed14}</td>
</tr>
<tr>
<td>TDF300/FTC200+EFV600</td>
<td>${noOfPatientsHavingstockDispensed15}</td>
</tr>
<tr>
<td>d4T/3TC/NVP (30/150/200)mg</td>
<td>${noOfPatientsHavingstockDispensed16}</td>
</tr>
<tr>
<td>d4T30/3TC150+NVP200</td>
<td>${noOfPatientsHavingstockDispensed17}</td>
</tr>
<tr>
<td>d4T/3TC/EFV (30/150/600)mg</td>
<td>${noOfPatientsHavingstockDispensed18}</td>
</tr>
<tr>
<td>d4T30/3TC150+EFV600</td>
<td>${noOfPatientsHavingstockDispensed19}</td>
</tr>
<tr>
<td>TDF/FTC/DTG</td>
<td>${noOfPatientsHavingstockDispensed20}</td>
</tr>
<tr>
<td>TDF/3TC/DTG</td>
<td>${noOfPatientsHavingstockDispensed21}</td>
</tr>
<tr>
<td>ABC600/3TC300 + EFV600</td>
<td>${noOfPatientsHavingstockDispensed22}</td>
</tr>
<tr>
<td>ABC/3TC/DTG</td>
<td>${noOfPatientsHavingstockDispensed23}</td>
</tr>
<tr>
<td>ABC/3TC/NVP</td>
<td>${noOfPatientsHavingstockDispensed24}</td>
</tr>
<tr>
<td>ABC/FTC/EFV</td>
<td>${noOfPatientsHavingstockDispensed25}</td>
</tr>
<tr>
<td>ABC/FTC/DTG</td>
<td>${noOfPatientsHavingstockDispensed26}</td>
</tr>
<tr>
<td>ABC/FTC/NVP</td>
<td>${noOfPatientsHavingstockDispensed27}</td>
</tr>
<tr>
<td>AZT/3TC/LPV/r (300/150/200/50)mg</td>
<td>${noOfPatientsHavingstockDispensed28}</td>
</tr>
<tr>
<td>AZT300/3TC150 + LPV/r200/50</td>
<td>${noOfPatientsHavingstockDispensed29}</td>
</tr>
<tr>
<td>TDF/3TC/LPV/r (300/300/200/50)mg</td>
<td>${noOfPatientsHavingstockDispensed30}</td>
</tr>
<tr>
<td>TDF300/3TC300 + LPV/r200/50</td>
<td>${noOfPatientsHavingstockDispensed31}</td>
</tr>
<tr>
<td>TDF/FTC/LPV/r (300/200/200/50)mg</td>
<td>${noOfPatientsHavingstockDispensed32}</td>
</tr>
<tr>
<td>TDF300/FTC200 + LPV/r200/50</td>
<td>${noOfPatientsHavingstockDispensed33}</td>
</tr>
<tr>
<td>TDF/ABC/LPV/r(300/300/200/50)mg</td>
<td>${noOfPatientsHavingstockDispensed34}</td>
</tr>
<tr>
<td>TDF/3TC/NVP (300/300/200)mg</td>
<td>${noOfPatientsHavingstockDispensed35}</td>
</tr>
<tr>
<td>ABC600/3TC300+ LPV/r200/50</td>
<td>${noOfPatientsHavingstockDispensed36}</td>
</tr>
<tr>
<td>ABC/3TC/ATV/r</td>
<td>${noOfPatientsHavingstockDispensed37}</td>
</tr>
<tr>
<td>AZT/3TC/ATV/r</td>
<td>${noOfPatientsHavingstockDispensed38}</td>
</tr>
<tr>
<td>TDF/3TC/ATV/r</td>
<td>${noOfPatientsHavingstockDispensed39}</td>
</tr>
<tr>
<td>AZT300/3TC150 + TDF300+ LPV/r200/50</td>
<td>${noOfPatientsHavingstockDispensed40}</td>
</tr>
</div>